SAN ANTONIO, TEXAS -- (Marketwired) -- 07/08/13

Bio-Solutions Corp. (OTCQB:BISU)(PINKSHEETS:BISU) (www.BioSolutionsCorp.com) has done it! In this first step to the company's expansion process across the USA and commitment to growth across America, management celebrates the national roll-out of its flagship product Type2Defense(TM) on the Healthy Provisions Amazon store via its partnership agreement with Kee Holdings Inc. The product can be purchased by following the online ordering link on the company website at: www.biosolutionscorp.com.

Kee Holdings Inc. is a leading procurer of health, nutrition and wellness products leading the way to many of the internet giants online today. Since 2006, Kee Holdings has grown to represent over 7,500 well-known consumer products and offers both wholesale and drop ship fulfillment strategies to clients such as Amazon.com and Overstock.com. Kee Holdings will be managing all product orders and shipping for Bio-Solution Corp's on-line sales.

Type2Defense(TM) is a new dietary supplement that has been developed to help support healthy blood glucose levels in health-conscious individuals and those diagnosed with Type 2 Diabetes. The Product's goal is to provide a safe and natural supplement that will assist in the stabilization of healthy glucose levels along with providing strong antioxidants.

"We are very excited to be bringing Type2Defense(TM) to the consumer on the Healthy Provisions Amazon store and we highly appreciate the support that Amazon and its partners offer to manufacturers and suppliers. We believe that there is a growing market place that lacks adequate healthy tools to maintain healthy blood glucose levels. Type2Defense(TM) is aimed at filling in that gap and our company is confident that it will benefit from the $15 billion dollar U.S diabetes market," said Bill Gallagher, president and CEO at Bio-Solutions Corporation.

Consumers can find more information about the product by going to http://www.biosolutionscorp.com/products/.

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: This release includes forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. All statements which address actual results could differ materially from those expressed or implied in forward-looking statements. These statements are made on the basis of management's views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as management "believes," "expects," "anticipates," "foresees," "forecasts," "estimates" or other words or phrases of similar import. Similarly, statements in this release that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. Management cautions that the ability to attract clients and generate business may be affected by a decline in the Company's financial ratings, the competitive environment, the Company's ability to raise sufficient capital to meet the collateral requirements associated with its current business and to fund the Company's continuing operations and changes in market conditions.

Contacts:
Bio-Solutions Corp.
William Gallagher
Chief Executive Officer
210-373-8104
info@biosolutionscorp.com

Bio-Solutions Corp.
Josh Williams
Endorsement Deal Coordinator
312-636-1471
joshwilliams0626@yahoo.com
www.biosolutionscorp.com